BACKGROUND & AIMS: Obesity has been associated with increased risk for colorectal adenoma, although its role as a risk factor after polypectomy for recurrence is unclear. Therefore, we sought to evaluate the effect of anthropometric measures of obesity on adenoma after polypectomy. METHODS: Subjects with baseline adenomas (n = 2465) and follow-up colonoscopy data were drawn from 2 randomized trials designed to prevent adenoma recurrence. RESULTS: Over a mean follow-up period of 3.1 years presence of a body mass index (BMI) > or = 30 kg/m2 was associated with a nonsignificant 17% increase in the odds for any adenoma recurrence among all subjects (odds ratio [OR], 1.17; 95% confidence interval [CI], 0.92-1.48). This result was confined to men (OR, 1.36; 95% CI, 1.01-1.83) and not observed for women (OR, 0.90; 95% CI, 0.60-1.33). Results for waist circumference did not reach statistical significance, although trends were similar to those for BMI. Analyses of the effects of obesity on more clinically significant lesions demonstrated that high BMI was a slightly stronger risk factor for advanced adenoma recurrences in men (OR, 1.62; 95% CI, 1.04-2.53) when compared with non-advanced lesions (OR, 1.26; 95% CI, 0.91-1.75). In addition, we observed an association for obesity and odds of adenoma recurrence among participants reporting a family history of colorectal cancer (OR, 2.25; 95% CI, 1.32-3.84) but not for those without (OR, 1.00; 95% CI, 0.77 to 1.31; P(int) = P = .008). CONCLUSIONS: Our results support obesity as a risk factor for subsequent short-interval (mean follow-up time 3.1 years) development of colorectal adenomas, particularly among men and persons with a family history of colorectal cancer. Furthermore, obesity in men appears to be strongly associated with the development of clinically advanced lesions.
BACKGROUND & AIMS:Obesity has been associated with increased risk for colorectal adenoma, although its role as a risk factor after polypectomy for recurrence is unclear. Therefore, we sought to evaluate the effect of anthropometric measures of obesity on adenoma after polypectomy. METHODS: Subjects with baseline adenomas (n = 2465) and follow-up colonoscopy data were drawn from 2 randomized trials designed to prevent adenoma recurrence. RESULTS: Over a mean follow-up period of 3.1 years presence of a body mass index (BMI) > or = 30 kg/m2 was associated with a nonsignificant 17% increase in the odds for any adenoma recurrence among all subjects (odds ratio [OR], 1.17; 95% confidence interval [CI], 0.92-1.48). This result was confined to men (OR, 1.36; 95% CI, 1.01-1.83) and not observed for women (OR, 0.90; 95% CI, 0.60-1.33). Results for waist circumference did not reach statistical significance, although trends were similar to those for BMI. Analyses of the effects of obesity on more clinically significant lesions demonstrated that high BMI was a slightly stronger risk factor for advanced adenoma recurrences in men (OR, 1.62; 95% CI, 1.04-2.53) when compared with non-advanced lesions (OR, 1.26; 95% CI, 0.91-1.75). In addition, we observed an association for obesity and odds of adenoma recurrence among participants reporting a family history of colorectal cancer (OR, 2.25; 95% CI, 1.32-3.84) but not for those without (OR, 1.00; 95% CI, 0.77 to 1.31; P(int) = P = .008). CONCLUSIONS: Our results support obesity as a risk factor for subsequent short-interval (mean follow-up time 3.1 years) development of colorectal adenomas, particularly among men and persons with a family history of colorectal cancer. Furthermore, obesity in men appears to be strongly associated with the development of clinically advanced lesions.
Authors: Sidney J Winawer; Ann G Zauber; Robert H Fletcher; Jonathon S Stillman; Michael J O'brien; Bernard Levin; Robert A Smith; David A Lieberman; Randall W Burt; Theodore R Levin; John H Bond; Durado Brooks; Tim Byers; Neil Hyman; Lynne Kirk; Alan Thorson; Clifford Simmang; David Johnson; Douglas K Rex Journal: CA Cancer J Clin Date: 2006 May-Jun Impact factor: 508.702
Authors: A Schatzkin; E Lanza; D Corle; P Lance; F Iber; B Caan; M Shike; J Weissfeld; R Burt; M R Cooper; J W Kikendall; J Cahill Journal: N Engl J Med Date: 2000-04-20 Impact factor: 91.245
Authors: Robert J MacInnis; Dallas R English; John L Hopper; Dorota M Gertig; Andrew M Haydon; Graham G Giles Journal: Int J Cancer Date: 2006-03-15 Impact factor: 7.396
Authors: Jeroen C van Rijn; Johannes B Reitsma; Jaap Stoker; Patrick M Bossuyt; Sander J van Deventer; Evelien Dekker Journal: Am J Gastroenterol Date: 2006-02 Impact factor: 10.864
Authors: A Bosy-Westphal; C Geisler; S Onur; O Korth; O Selberg; J Schrezenmeir; M J Müller Journal: Int J Obes (Lond) Date: 2006-03 Impact factor: 5.095
Authors: Christine L Sardo Molmenti; Elizabeth A Hibler; Erin L Ashbeck; Cynthia A Thomson; David O Garcia; Denise Roe; Robin B Harris; Peter Lance; Martin Cisneroz; Maria Elena Martinez; Patricia A Thompson; Elizabeth T Jacobs Journal: Cancer Causes Control Date: 2014-07-25 Impact factor: 2.506
Authors: Karen J Wernli; Polly A Newcomb; Yinghui Wang; Karen W Makar; Mazyar Shadman; Victoria M Chia; Andrea Burnett-Hartman; Michelle A Wurscher; Yingye Zheng; Margaret T Mandelson Journal: Growth Horm IGF Res Date: 2010-05-26 Impact factor: 2.372
Authors: Elizabeth T Jacobs; Dennis J Ahnen; Erin L Ashbeck; John A Baron; E Robert Greenberg; Peter Lance; David A Lieberman; Gail McKeown-Eyssen; Arthur Schatzkin; Patricia A Thompson; María Elena Martínez Journal: Am J Epidemiol Date: 2009-01-15 Impact factor: 4.897
Authors: Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb Journal: Am J Epidemiol Date: 2013-03-03 Impact factor: 4.897
Authors: Cari M Kitahara; Sonja I Berndt; Amy Berrington de González; Helen G Coleman; Robert E Schoen; Richard B Hayes; Wen-Yi Huang Journal: J Clin Oncol Date: 2013-05-28 Impact factor: 44.544
Authors: Michael F Leitzmann; Andrew Flood; Leah M Ferrucci; Philip Schoenfeld; Brooks Cash; Arthur Schatzkin; Amanda J Cross Journal: Cancer Causes Control Date: 2009-04-22 Impact factor: 2.506